Benznidazole-Resistance in Trypanosoma cruzi Is a Readily Acquired Trait That Can Arise Independently in a Single Population

Nifurtimox Activation by Trypanosomal Type I Nitroreductases Generates Cytotoxic Nitrile Metabolites

(2011) Belinda S. Hall et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Shotgun Sequencing Analysis of Trypanosoma cruzi I Sylvio X10/1 and Comparison with T. cruzi VI CL Brener

(2011) Oscar Franzén et al.   PLoS Neglected Tropical Diseases

Tolerance of Benznidazole in Treatment of Chagas' Disease in Adults

(2010) M.-J. Pinazo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6

(2010) Nicola Baker et al.   MOLECULAR AND BIOCHEMICAL PARASITOLOGY

Exploiting the Drug-Activating Properties of a Novel Trypanosomal Nitroreductase

(2009) B. S. Hall et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

An Estimate of the Burden of Chagas Disease in the United States

(2009) Caryn Bern et al.   CLINICAL INFECTIOUS DISEASES

Trypanocidal drugs: mechanisms, resistance and new targets

(2009) Shane R. Wilkinson et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy

(2009) Álvaro Moncayo et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Haplotype identification within Trypanosoma cruzi I in Colombian isolates from several reservoirs, vectors and humans

(2008) Alejandra Falla et al.   ACTA TROPICA

A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes

(2008) Shane R. Wilkinson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA